Global Fibromyalgia Therapeutics Drugs Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Fibromyalgia Therapeutics Drugs market is segmented into
The Fibromyalgia Therapeutics Drugs market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Fibromyalgia Therapeutics Drugs market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Fibromyalgia Therapeutics Drugs market include:
Segment by Type, the Fibromyalgia Therapeutics Drugs market is segmented into
- Cymbalta (Duloxetine)
- Savella (Milnacipran)
- Lyrica (Pregabalin)
- Pancuronium
- Others
- Hospital
- Clinic
- Others
The Fibromyalgia Therapeutics Drugs market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Fibromyalgia Therapeutics Drugs market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Fibromyalgia Therapeutics Drugs market include:
- Pfizer
- Eli Lilly
- Actavis
- Merck Sharp and Dohme
- Daiichi Sankyo
- Innovative Med Concepts
- Meda
- Meiji Seika
- Switch Biotech
- Theravance
- Zynerba Pharmaceuticals
- Tonix Pharmaceuticals Holding Corp. (TNXP)
- Daiichi Sankyo
- Forest Pharmaceuticals, Inc.
- Boehringer Ingelheim GmbH
- Pierre Fabre Mdicament
1 FIBROMYALGIA THERAPEUTICS DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Fibromyalgia Therapeutics Drugs
1.2 Fibromyalgia Therapeutics Drugs Segment by Type
1.2.1 Global Fibromyalgia Therapeutics Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Fibromyalgia Therapeutics Drugs Segment by Application
1.3.1 Fibromyalgia Therapeutics Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Fibromyalgia Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Fibromyalgia Therapeutics Drugs Revenue 2015-2026
1.4.2 Global Fibromyalgia Therapeutics Drugs Sales 2015-2026
1.4.3 Fibromyalgia Therapeutics Drugs Market Size by Region: 2020 Versus 2026
1.5 Fibromyalgia Therapeutics Drugs Industry
1.6 Fibromyalgia Therapeutics Drugs Market Trends
2 GLOBAL FIBROMYALGIA THERAPEUTICS DRUGS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Fibromyalgia Therapeutics Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Fibromyalgia Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Fibromyalgia Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Fibromyalgia Therapeutics Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Fibromyalgia Therapeutics Drugs Players (Opinion Leaders)
3 FIBROMYALGIA THERAPEUTICS DRUGS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Fibromyalgia Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Fibromyalgia Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Fibromyalgia Therapeutics Drugs Sales by Country
3.3.2 North America Fibromyalgia Therapeutics Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Fibromyalgia Therapeutics Drugs Sales by Country
3.4.2 Europe Fibromyalgia Therapeutics Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Fibromyalgia Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Fibromyalgia Therapeutics Drugs Sales by Country
3.6.2 Latin America Fibromyalgia Therapeutics Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL FIBROMYALGIA THERAPEUTICS DRUGS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2015-2020)
4.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Fibromyalgia Therapeutics Drugs Price Market Share by Type (2015-2020)
4.4 Global Fibromyalgia Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL FIBROMYALGIA THERAPEUTICS DRUGS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2015-2020)
5.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Fibromyalgia Therapeutics Drugs Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN FIBROMYALGIA THERAPEUTICS DRUGS BUSINESS
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description, Business Overview and Total Revenue
6.2.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Eli Lilly Products Offered
6.2.5 Eli Lilly Recent Development
6.3 Actavis
6.3.1 Actavis Corporation Information
6.3.2 Actavis Description, Business Overview and Total Revenue
6.3.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Actavis Products Offered
6.3.5 Actavis Recent Development
6.4 Merck Sharp and Dohme
6.4.1 Merck Sharp and Dohme Corporation Information
6.4.2 Merck Sharp and Dohme Description, Business Overview and Total Revenue
6.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Sharp and Dohme Products Offered
6.4.5 Merck Sharp and Dohme Recent Development
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description, Business Overview and Total Revenue
6.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Daiichi Sankyo Products Offered
6.5.5 Daiichi Sankyo Recent Development
6.6 Innovative Med Concepts
6.6.1 Innovative Med Concepts Corporation Information
6.6.2 Innovative Med Concepts Description, Business Overview and Total Revenue
6.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Innovative Med Concepts Products Offered
6.6.5 Innovative Med Concepts Recent Development
6.7 Meda
6.6.1 Meda Corporation Information
6.6.2 Meda Description, Business Overview and Total Revenue
6.6.3 Meda Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Meda Products Offered
6.7.5 Meda Recent Development
6.8 Meiji Seika
6.8.1 Meiji Seika Corporation Information
6.8.2 Meiji Seika Description, Business Overview and Total Revenue
6.8.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Meiji Seika Products Offered
6.8.5 Meiji Seika Recent Development
6.9 Switch Biotech
6.9.1 Switch Biotech Corporation Information
6.9.2 Switch Biotech Description, Business Overview and Total Revenue
6.9.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Switch Biotech Products Offered
6.9.5 Switch Biotech Recent Development
6.10 Theravance
6.10.1 Theravance Corporation Information
6.10.2 Theravance Description, Business Overview and Total Revenue
6.10.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Theravance Products Offered
6.10.5 Theravance Recent Development
6.11 Zynerba Pharmaceuticals
6.11.1 Zynerba Pharmaceuticals Corporation Information
6.11.2 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Zynerba Pharmaceuticals Products Offered
6.11.5 Zynerba Pharmaceuticals Recent Development
6.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
6.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information
6.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Products Offered
6.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
6.13 Daiichi Sankyo
6.13.1 Daiichi Sankyo Corporation Information
6.13.2 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Daiichi Sankyo Products Offered
6.13.5 Daiichi Sankyo Recent Development
6.14 Forest Pharmaceuticals, Inc.
6.14.1 Forest Pharmaceuticals, Inc. Corporation Information
6.14.2 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Forest Pharmaceuticals, Inc. Products Offered
6.14.5 Forest Pharmaceuticals, Inc. Recent Development
6.15 Boehringer Ingelheim GmbH
6.15.1 Boehringer Ingelheim GmbH Corporation Information
6.15.2 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Boehringer Ingelheim GmbH Products Offered
6.15.5 Boehringer Ingelheim GmbH Recent Development
6.16 Pierre Fabre Mdicament
6.16.1 Pierre Fabre Mdicament Corporation Information
6.16.2 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Pierre Fabre Mdicament Products Offered
6.16.5 Pierre Fabre Mdicament Recent Development
7 FIBROMYALGIA THERAPEUTICS DRUGS MANUFACTURING COST ANALYSIS
7.1 Fibromyalgia Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Fibromyalgia Therapeutics Drugs
7.4 Fibromyalgia Therapeutics Drugs Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Fibromyalgia Therapeutics Drugs Distributors List
8.3 Fibromyalgia Therapeutics Drugs Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Fibromyalgia Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Fibromyalgia Therapeutics Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Fibromyalgia Therapeutics Drugs by Type (2021-2026)
10.2 Fibromyalgia Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Fibromyalgia Therapeutics Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Fibromyalgia Therapeutics Drugs by Application (2021-2026)
10.3 Fibromyalgia Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Fibromyalgia Therapeutics Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Fibromyalgia Therapeutics Drugs by Region (2021-2026)
10.4 North America Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.5 Europe Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.7 Latin America Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Fibromyalgia Therapeutics Drugs
1.2 Fibromyalgia Therapeutics Drugs Segment by Type
1.2.1 Global Fibromyalgia Therapeutics Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Fibromyalgia Therapeutics Drugs Segment by Application
1.3.1 Fibromyalgia Therapeutics Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Fibromyalgia Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Fibromyalgia Therapeutics Drugs Revenue 2015-2026
1.4.2 Global Fibromyalgia Therapeutics Drugs Sales 2015-2026
1.4.3 Fibromyalgia Therapeutics Drugs Market Size by Region: 2020 Versus 2026
1.5 Fibromyalgia Therapeutics Drugs Industry
1.6 Fibromyalgia Therapeutics Drugs Market Trends
2 GLOBAL FIBROMYALGIA THERAPEUTICS DRUGS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Fibromyalgia Therapeutics Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Fibromyalgia Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Fibromyalgia Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Fibromyalgia Therapeutics Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Fibromyalgia Therapeutics Drugs Players (Opinion Leaders)
3 FIBROMYALGIA THERAPEUTICS DRUGS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Fibromyalgia Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Fibromyalgia Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Fibromyalgia Therapeutics Drugs Sales by Country
3.3.2 North America Fibromyalgia Therapeutics Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Fibromyalgia Therapeutics Drugs Sales by Country
3.4.2 Europe Fibromyalgia Therapeutics Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Fibromyalgia Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Fibromyalgia Therapeutics Drugs Sales by Country
3.6.2 Latin America Fibromyalgia Therapeutics Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL FIBROMYALGIA THERAPEUTICS DRUGS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2015-2020)
4.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Fibromyalgia Therapeutics Drugs Price Market Share by Type (2015-2020)
4.4 Global Fibromyalgia Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL FIBROMYALGIA THERAPEUTICS DRUGS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2015-2020)
5.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Fibromyalgia Therapeutics Drugs Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN FIBROMYALGIA THERAPEUTICS DRUGS BUSINESS
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description, Business Overview and Total Revenue
6.2.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Eli Lilly Products Offered
6.2.5 Eli Lilly Recent Development
6.3 Actavis
6.3.1 Actavis Corporation Information
6.3.2 Actavis Description, Business Overview and Total Revenue
6.3.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Actavis Products Offered
6.3.5 Actavis Recent Development
6.4 Merck Sharp and Dohme
6.4.1 Merck Sharp and Dohme Corporation Information
6.4.2 Merck Sharp and Dohme Description, Business Overview and Total Revenue
6.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Merck Sharp and Dohme Products Offered
6.4.5 Merck Sharp and Dohme Recent Development
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description, Business Overview and Total Revenue
6.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Daiichi Sankyo Products Offered
6.5.5 Daiichi Sankyo Recent Development
6.6 Innovative Med Concepts
6.6.1 Innovative Med Concepts Corporation Information
6.6.2 Innovative Med Concepts Description, Business Overview and Total Revenue
6.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Innovative Med Concepts Products Offered
6.6.5 Innovative Med Concepts Recent Development
6.7 Meda
6.6.1 Meda Corporation Information
6.6.2 Meda Description, Business Overview and Total Revenue
6.6.3 Meda Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Meda Products Offered
6.7.5 Meda Recent Development
6.8 Meiji Seika
6.8.1 Meiji Seika Corporation Information
6.8.2 Meiji Seika Description, Business Overview and Total Revenue
6.8.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Meiji Seika Products Offered
6.8.5 Meiji Seika Recent Development
6.9 Switch Biotech
6.9.1 Switch Biotech Corporation Information
6.9.2 Switch Biotech Description, Business Overview and Total Revenue
6.9.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Switch Biotech Products Offered
6.9.5 Switch Biotech Recent Development
6.10 Theravance
6.10.1 Theravance Corporation Information
6.10.2 Theravance Description, Business Overview and Total Revenue
6.10.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Theravance Products Offered
6.10.5 Theravance Recent Development
6.11 Zynerba Pharmaceuticals
6.11.1 Zynerba Pharmaceuticals Corporation Information
6.11.2 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Zynerba Pharmaceuticals Products Offered
6.11.5 Zynerba Pharmaceuticals Recent Development
6.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
6.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information
6.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Products Offered
6.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
6.13 Daiichi Sankyo
6.13.1 Daiichi Sankyo Corporation Information
6.13.2 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Daiichi Sankyo Products Offered
6.13.5 Daiichi Sankyo Recent Development
6.14 Forest Pharmaceuticals, Inc.
6.14.1 Forest Pharmaceuticals, Inc. Corporation Information
6.14.2 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Forest Pharmaceuticals, Inc. Products Offered
6.14.5 Forest Pharmaceuticals, Inc. Recent Development
6.15 Boehringer Ingelheim GmbH
6.15.1 Boehringer Ingelheim GmbH Corporation Information
6.15.2 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Boehringer Ingelheim GmbH Products Offered
6.15.5 Boehringer Ingelheim GmbH Recent Development
6.16 Pierre Fabre Mdicament
6.16.1 Pierre Fabre Mdicament Corporation Information
6.16.2 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Description, Business Overview and Total Revenue
6.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Pierre Fabre Mdicament Products Offered
6.16.5 Pierre Fabre Mdicament Recent Development
7 FIBROMYALGIA THERAPEUTICS DRUGS MANUFACTURING COST ANALYSIS
7.1 Fibromyalgia Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Fibromyalgia Therapeutics Drugs
7.4 Fibromyalgia Therapeutics Drugs Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Fibromyalgia Therapeutics Drugs Distributors List
8.3 Fibromyalgia Therapeutics Drugs Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Fibromyalgia Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Fibromyalgia Therapeutics Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Fibromyalgia Therapeutics Drugs by Type (2021-2026)
10.2 Fibromyalgia Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Fibromyalgia Therapeutics Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Fibromyalgia Therapeutics Drugs by Application (2021-2026)
10.3 Fibromyalgia Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Fibromyalgia Therapeutics Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Fibromyalgia Therapeutics Drugs by Region (2021-2026)
10.4 North America Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.5 Europe Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.7 Latin America Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Fibromyalgia Therapeutics Drugs Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Comparison by Application: 2020 VS 2026
Table 3. Global Fibromyalgia Therapeutics Drugs Market Size by Type (Kg) (US$ Million) (2020 VS 2026)
Table 4. Global Key Fibromyalgia Therapeutics Drugs Manufacturers Covered in This Study
Table 5. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Manufacturers (2015-2020)
Table 6. Global Fibromyalgia Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Fibromyalgia Therapeutics Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Fibromyalgia Therapeutics Drugs Average Price (USD/g) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Fibromyalgia Therapeutics Drugs Sales Sites and Area Served
Table 11. Manufacturers Fibromyalgia Therapeutics Drugs Product Types
Table 12. Global Fibromyalgia Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Fibromyalgia Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Therapeutics Drugs as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Fibromyalgia Therapeutics Drugs Players
Table 16. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Region (2015-2020)
Table 17. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 21. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 25. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2015-2020) (Kg)
Table 29. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 33. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 37. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Type (2015-2020)
Table 41. Global Fibromyalgia Therapeutics Drugs Sales Share by Type (2015-2020)
Table 42. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Fibromyalgia Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 44. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Type (2015-2020)
Table 45. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Application (2015-2020)
Table 46. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Fibromyalgia Therapeutics Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Fibromyalgia Therapeutics Drugs Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Eli Lilly Fibromyalgia Therapeutics Drugs Corporation Information
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 56. Eli Lilly Main Product
Table 57. Eli Lilly Recent Development
Table 58. Actavis Fibromyalgia Therapeutics Drugs Corporation Information
Table 59. Actavis Corporation Information
Table 60. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 61. Actavis Main Product
Table 62. Actavis Recent Development
Table 63. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Corporation Information
Table 64. Merck Sharp and Dohme Corporation Information
Table 65. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 66. Merck Sharp and Dohme Main Product
Table 67. Merck Sharp and Dohme Recent Development
Table 68. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Corporation Information
Table 69. Daiichi Sankyo Corporation Information
Table 70. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 71. Daiichi Sankyo Main Product
Table 72. Daiichi Sankyo Recent Development
Table 73. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Corporation Information
Table 74. Innovative Med Concepts Corporation Information
Table 75. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 76. Innovative Med Concepts Main Product
Table 77. Innovative Med Concepts Recent Development
Table 78. Meda Fibromyalgia Therapeutics Drugs Corporation Information
Table 79. Meda Corporation Information
Table 80. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 81. Meda Main Product
Table 82. Meda Recent Development
Table 83. Meiji Seika Fibromyalgia Therapeutics Drugs Corporation Information
Table 84. Meiji Seika Corporation Information
Table 85. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 86. Meiji Seika Main Product
Table 87. Meiji Seika Recent Development
Table 88. Switch Biotech Fibromyalgia Therapeutics Drugs Corporation Information
Table 89. Switch Biotech Corporation Information
Table 90. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 91. Switch Biotech Main Product
Table 92. Switch Biotech Recent Development
Table 93. Theravance Fibromyalgia Therapeutics Drugs Corporation Information
Table 94. Theravance Corporation Information
Table 95. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 96. Theravance Main Product
Table 97. Theravance Recent Development
Table 98. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Corporation Information
Table 99. Zynerba Pharmaceuticals Corporation Information
Table 100. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 101. Zynerba Pharmaceuticals Main Product
Table 102. Zynerba Pharmaceuticals Recent Development
Table 103. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Corporation Information
Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information
Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Main Product
Table 107. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
Table 108. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Corporation Information
Table 109. Daiichi Sankyo Corporation Information
Table 110. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 111. Daiichi Sankyo Main Product
Table 112. Daiichi Sankyo Recent Development
Table 113. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Corporation Information
Table 114. Forest Pharmaceuticals, Inc. Corporation Information
Table 115. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 116. Forest Pharmaceuticals, Inc. Main Product
Table 117. Forest Pharmaceuticals, Inc. Recent Development
Table 118. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Corporation Information
Table 119. Boehringer Ingelheim GmbH Corporation Information
Table 120. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 121. Boehringer Ingelheim GmbH Main Product
Table 122. Boehringer Ingelheim GmbH Recent Development
Table 123. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Corporation Information
Table 124. Pierre Fabre Mdicament Corporation Information
Table 125. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 126. Pierre Fabre Mdicament Main Product
Table 127. Pierre Fabre Mdicament Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Fibromyalgia Therapeutics Drugs Distributors List
Table 131. Fibromyalgia Therapeutics Drugs Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Forecast by Type (2021-2026)
Table 136. Global Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Forecast by Application (2021-2026)
Table 140. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Forecast by Region (2021-2026)
Table 142. Global Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Fibromyalgia Therapeutics Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Fibromyalgia Therapeutics Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 1. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Comparison by Application: 2020 VS 2026
Table 3. Global Fibromyalgia Therapeutics Drugs Market Size by Type (Kg) (US$ Million) (2020 VS 2026)
Table 4. Global Key Fibromyalgia Therapeutics Drugs Manufacturers Covered in This Study
Table 5. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Manufacturers (2015-2020)
Table 6. Global Fibromyalgia Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Fibromyalgia Therapeutics Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Fibromyalgia Therapeutics Drugs Average Price (USD/g) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Fibromyalgia Therapeutics Drugs Sales Sites and Area Served
Table 11. Manufacturers Fibromyalgia Therapeutics Drugs Product Types
Table 12. Global Fibromyalgia Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Fibromyalgia Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Therapeutics Drugs as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Fibromyalgia Therapeutics Drugs Players
Table 16. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Region (2015-2020)
Table 17. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 21. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 25. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2015-2020) (Kg)
Table 29. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 33. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2015-2020) (Kg)
Table 37. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Type (2015-2020)
Table 41. Global Fibromyalgia Therapeutics Drugs Sales Share by Type (2015-2020)
Table 42. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Fibromyalgia Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 44. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Type (2015-2020)
Table 45. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Application (2015-2020)
Table 46. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Fibromyalgia Therapeutics Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Fibromyalgia Therapeutics Drugs Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Eli Lilly Fibromyalgia Therapeutics Drugs Corporation Information
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 56. Eli Lilly Main Product
Table 57. Eli Lilly Recent Development
Table 58. Actavis Fibromyalgia Therapeutics Drugs Corporation Information
Table 59. Actavis Corporation Information
Table 60. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 61. Actavis Main Product
Table 62. Actavis Recent Development
Table 63. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Corporation Information
Table 64. Merck Sharp and Dohme Corporation Information
Table 65. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 66. Merck Sharp and Dohme Main Product
Table 67. Merck Sharp and Dohme Recent Development
Table 68. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Corporation Information
Table 69. Daiichi Sankyo Corporation Information
Table 70. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 71. Daiichi Sankyo Main Product
Table 72. Daiichi Sankyo Recent Development
Table 73. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Corporation Information
Table 74. Innovative Med Concepts Corporation Information
Table 75. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 76. Innovative Med Concepts Main Product
Table 77. Innovative Med Concepts Recent Development
Table 78. Meda Fibromyalgia Therapeutics Drugs Corporation Information
Table 79. Meda Corporation Information
Table 80. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 81. Meda Main Product
Table 82. Meda Recent Development
Table 83. Meiji Seika Fibromyalgia Therapeutics Drugs Corporation Information
Table 84. Meiji Seika Corporation Information
Table 85. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 86. Meiji Seika Main Product
Table 87. Meiji Seika Recent Development
Table 88. Switch Biotech Fibromyalgia Therapeutics Drugs Corporation Information
Table 89. Switch Biotech Corporation Information
Table 90. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 91. Switch Biotech Main Product
Table 92. Switch Biotech Recent Development
Table 93. Theravance Fibromyalgia Therapeutics Drugs Corporation Information
Table 94. Theravance Corporation Information
Table 95. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 96. Theravance Main Product
Table 97. Theravance Recent Development
Table 98. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Corporation Information
Table 99. Zynerba Pharmaceuticals Corporation Information
Table 100. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 101. Zynerba Pharmaceuticals Main Product
Table 102. Zynerba Pharmaceuticals Recent Development
Table 103. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Corporation Information
Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information
Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Main Product
Table 107. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
Table 108. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Corporation Information
Table 109. Daiichi Sankyo Corporation Information
Table 110. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 111. Daiichi Sankyo Main Product
Table 112. Daiichi Sankyo Recent Development
Table 113. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Corporation Information
Table 114. Forest Pharmaceuticals, Inc. Corporation Information
Table 115. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 116. Forest Pharmaceuticals, Inc. Main Product
Table 117. Forest Pharmaceuticals, Inc. Recent Development
Table 118. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Corporation Information
Table 119. Boehringer Ingelheim GmbH Corporation Information
Table 120. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 121. Boehringer Ingelheim GmbH Main Product
Table 122. Boehringer Ingelheim GmbH Recent Development
Table 123. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Corporation Information
Table 124. Pierre Fabre Mdicament Corporation Information
Table 125. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020)
Table 126. Pierre Fabre Mdicament Main Product
Table 127. Pierre Fabre Mdicament Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Fibromyalgia Therapeutics Drugs Distributors List
Table 131. Fibromyalgia Therapeutics Drugs Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Forecast by Type (2021-2026)
Table 136. Global Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Forecast by Application (2021-2026)
Table 140. Global Fibromyalgia Therapeutics Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Fibromyalgia Therapeutics Drugs Sales (Kg) Forecast by Region (2021-2026)
Table 142. Global Fibromyalgia Therapeutics Drugs Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Fibromyalgia Therapeutics Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Fibromyalgia Therapeutics Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Fibromyalgia Therapeutics Drugs
Figure 2. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Cymbalta (Duloxetine) Product Picture
Figure 4. Savella (Milnacipran) Product Picture
Figure 5. Lyrica (Pregabalin) Product Picture
Figure 6. Pancuronium Product Picture
Figure 7. Others Product Picture
Figure 8. Global Fibromyalgia Therapeutics Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Fibromyalgia Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Fibromyalgia Therapeutics Drugs Sales Capacity (Kg) (2015-2026)
Figure 14. Global Fibromyalgia Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Fibromyalgia Therapeutics Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Fibromyalgia Therapeutics Drugs Revenue in 2019
Figure 18. Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region in 2019
Figure 21. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 23. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 24. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 25. U.S. Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 26. U.S. Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 28. Canada Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 30. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 31. Germany Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 32. Germany Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 34. France Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.K. Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 38. Italy Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 40. Russia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region in 2019
Figure 42. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 43. China Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 44. China Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 46. Japan Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 48. South Korea Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 50. India Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 52. Australia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 54. Taiwan Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 56. Indonesia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 58. Thailand Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 60. Malaysia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 62. Philippines Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 64. Vietnam Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 66. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 67. Mexico Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 68. Mexico Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 70. Brazil Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 72. Argentina Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 75. Turkey Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 76. Turkey Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 78. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. UAE Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 80. UAE Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Fibromyalgia Therapeutics Drugs by Type (2015-2020)
Figure 82. Sales Market Share of Fibromyalgia Therapeutics Drugs by Type in 2019
Figure 83. Revenue Share of Fibromyalgia Therapeutics Drugs by Type (2015-2020)
Figure 84. Revenue Market Share of Fibromyalgia Therapeutics Drugs by Type in 2019
Figure 85. Global Fibromyalgia Therapeutics Drugs Sales Growth by Type (2015-2020) (Kg)
Figure 86. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 87. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Fibromyalgia Therapeutics Drugs by Application (2015-2020)
Figure 89. Global Revenue Share of Fibromyalgia Therapeutics Drugs by Application in 2020
Figure 90. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Merck Sharp and Dohme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Innovative Med Concepts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Meda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Meiji Seika Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Switch Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Theravance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Zynerba Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Tonix Pharmaceuticals Holding Corp. (TNXP) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Forest Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Pierre Fabre Mdicament Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Fibromyalgia Therapeutics Drugs
Figure 108. Manufacturing Process Analysis of Fibromyalgia Therapeutics Drugs
Figure 109. Fibromyalgia Therapeutics Drugs Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 114. North America Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
Figure 1. Picture of Fibromyalgia Therapeutics Drugs
Figure 2. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Cymbalta (Duloxetine) Product Picture
Figure 4. Savella (Milnacipran) Product Picture
Figure 5. Lyrica (Pregabalin) Product Picture
Figure 6. Pancuronium Product Picture
Figure 7. Others Product Picture
Figure 8. Global Fibromyalgia Therapeutics Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Fibromyalgia Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Fibromyalgia Therapeutics Drugs Sales Capacity (Kg) (2015-2026)
Figure 14. Global Fibromyalgia Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Fibromyalgia Therapeutics Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Fibromyalgia Therapeutics Drugs Revenue in 2019
Figure 18. Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region in 2019
Figure 21. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 23. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 24. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 25. U.S. Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 26. U.S. Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 28. Canada Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 30. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 31. Germany Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 32. Germany Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 34. France Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.K. Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 38. Italy Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 40. Russia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region in 2019
Figure 42. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 43. China Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 44. China Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 46. Japan Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 48. South Korea Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 50. India Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 52. Australia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 54. Taiwan Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 56. Indonesia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 58. Thailand Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 60. Malaysia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 62. Philippines Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 64. Vietnam Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 66. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 67. Mexico Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 68. Mexico Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 70. Brazil Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 72. Argentina Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 75. Turkey Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 76. Turkey Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 78. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. UAE Fibromyalgia Therapeutics Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 80. UAE Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Fibromyalgia Therapeutics Drugs by Type (2015-2020)
Figure 82. Sales Market Share of Fibromyalgia Therapeutics Drugs by Type in 2019
Figure 83. Revenue Share of Fibromyalgia Therapeutics Drugs by Type (2015-2020)
Figure 84. Revenue Market Share of Fibromyalgia Therapeutics Drugs by Type in 2019
Figure 85. Global Fibromyalgia Therapeutics Drugs Sales Growth by Type (2015-2020) (Kg)
Figure 86. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 87. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Fibromyalgia Therapeutics Drugs by Application (2015-2020)
Figure 89. Global Revenue Share of Fibromyalgia Therapeutics Drugs by Application in 2020
Figure 90. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Merck Sharp and Dohme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Innovative Med Concepts Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Meda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Meiji Seika Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Switch Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Theravance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Zynerba Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Tonix Pharmaceuticals Holding Corp. (TNXP) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Forest Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Pierre Fabre Mdicament Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Fibromyalgia Therapeutics Drugs
Figure 108. Manufacturing Process Analysis of Fibromyalgia Therapeutics Drugs
Figure 109. Fibromyalgia Therapeutics Drugs Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 114. North America Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Fibromyalgia Therapeutics Drugs Sales (Kg) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
